RT @EHF_Official: The GARLIT study is the first multicenter study proving the efficacy and safety of galcanezumab in real-life. The treatme…
170 followers
271 followers
This is great for our long suffering difficult to treat migraine patients. Thankfully we have this already available for Leeds patients. @LTHTNEURO
2,990 followers
The GARLIT study is the first multicenter study proving the efficacy and safety of galcanezumab in real-life. The treatment extensively reduced MHDs and MMDs in hard-to-treat patients with HFEM or CM. Read more here https://t.co/dvS5j9v1RD https://t.co/3iM
705 followers
RT @NeuroPsychBMC: Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter pro…